The IgG4-Related Disease (IgG4-RD) market is undergoing a fundamental transformation, characterized by several key emerging trends. One dominant trend is the intense focus on developing and validating robust biomarkers beyond serum IgG4 levels. While elevated IgG4 is indicative, researchers are seeking more specific molecular markers that can predict disease activity, track treatment response,...